Laparoscopic Cystogastrostomy Versus Endoscopic Cystogastrostomy

Launched by ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI · Jan 18, 2014

Keywords

ClinConnect Summary

This study will be conducted in the Department of Surgical Disciplines and Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi. Patients with pancreatic pseudocyst will be randomized to two groups-

Group I- Laparoscopic management of the pseudocyst Group II- Endoscopic management of the pseudocyst

Patients will be randomized using computer generated randomized numbers in sealed envelopes to ensure concealed allocation with block randomization. The details of patients who do not meet inclusion criteria and those who refuse consent and reason for refusal of co...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Symptomatic patients with pseudocyst of size more than 6 cm, more than 6-8 weeks duration after an attack of acute pancreatitis.
• Exclusion Criteria:
• • Patients with chronic pancreatitis associated pseudocyst.
• • Patients who have undergone any form of intervention previously
• • Patients with significant co-morbidities
• • Patients unfit for general anesthesia
• • Bleeding disorders
• • Patients refusing consent
• • Patients having significant necrotic debris not considered fit for endoscopic drainage. The presence of necrotic debris will be assessed by ultrasound of the abdomen and if required magnetic resonance imaging. The volume of the cyst and that of necrotic debris will be calculated and significant debris will be defined as \>30% of debris volume/volume
• • Presence of a pseudoaneurysm

Trial Officials